Delivery Order SPE2DB25D3110-SPE2DB25FTCVE

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,567,202,673 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $5,044.30. The contract has a firm fixed price and a completion date of February 10, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,563,519,182 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a total ceiling value of $2,564.45. The contract is a firm fixed-price delivery order with a period of performance through February 2, 2024. This award is not designated as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,561,342,095 units of the Typhim VI 25 MCG/0.5 ML vaccine, with a ceiling value of $17,208.40. The contract type is firm fixed price, and the ultimate completion date is June 27, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,372,782 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The $4,257.62 firm-fixed-price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential medical...
This is a $39,598.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for the supply of 4,565,235,791 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a period of performance through July 25, 2024 and was awarded on July 24, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,563,238,642 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The firm fixed-price delivery order is valued at $5,197.13 and has a completion date of January 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products to federal agencies, particularly the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,712.24, is for the supply of 4,563,500,765 doses of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract is a firm fixed-price, with a period of performance through February 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of 4,565,164,918 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine, with a ceiling value of $2,052.60 and a completion date of July 17, 2024. The contract is a Firm Fixed Price (FFP) type and is not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the provision of 4,564,931,979 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $13,070.08. It is a firm fixed-price contract with a period of performance ending on June 18, 2024. Amerisourcebergen holds a larger...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides 4,566,403,909 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $9,363.10. The contract has a period of performance through November 13, 2024 and is a Firm Fixed Price, Delivery Order contract. This award is not associated with a set-aside designation, indicating open competition....
  • SPE2DB25D3110
    Indefinite Delivery Contract
  • SPE2DB25D3110-SPE2DB25FTCVE
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,670,234 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $2,879.76. The contract has a Firm Fixed Price pricing type and is a Delivery Order. The contract has an ultimate completion date of March 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/21/25, 9:48 AM